Aprea Therapeutics, Inc.
APRE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,972 | -$3,239 | -$3,933 | -$2,895 |
| Dep. & Amort. | $5 | $5 | $5 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $137 | $119 | $126 |
| Change in WC | -$339 | -$63 | $126 | -$708 |
| Other Non-Cash | $42 | $29 | $52 | -$39 |
| Operating Cash Flow | -$3,263 | -$3,131 | -$3,631 | -$3,511 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $371 | $400 | $56 | $141 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$15 | $0 | -$6 |
| Financing Cash Flow | $371 | $385 | $56 | $134 |
| Forex Effect | $78 | $3 | $1 | -$25 |
| Net Chg. in Cash | -$2,814 | -$2,743 | -$3,574 | -$3,401 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16,532 | $19,316 | $22,890 | $26,291 |
| End Cash | $13,718 | $16,573 | $19,316 | $22,890 |
| Free Cash Flow | -$3,263 | -$3,131 | -$3,631 | -$3,511 |